Trigeminal diagnostic pathway

Why the diagnostic pathway is central

Facial pain can have different origins and require different treatments. The trigeminal diagnostic pathway serves to reconstruct symptoms, examine facial sensitivity, and interpret tests within the clinical context before choosing a treatment.

At PONOS Clinic, trigeminal pain is addressed through a structured diagnostic pathway aimed at:

• distinguishing different clinical presentations
• avoiding inappropriate treatments
• defining the actual role of the trigeminal nerve in the pain

Not all facial pain is trigeminal neuralgia

A frequent error is considering all facial pain as “trigeminal neuralgia.” From a clinical perspective, it is instead fundamental to distinguish between:

• trigeminal neuralgia: classical, idiopathic, or secondary
• painful trigeminal neuropathy
• persistent facial pain, to be classified with a specific diagnosis
• headaches and trigeminal-autonomic syndromes

The word “atypical” describes pain that does not fit the expected pattern, but it does not identify a diagnosis on its own. The distinction between these presentations guides investigations and therapeutic choices.

The phases of the trigeminal diagnostic pathway

The specialist pathway for trigeminal pain

The visit integrates the pain history, clinical examination, previous therapies, and MRI. Further investigations are chosen based on the suspected diagnosis; selective blocks are not a mandatory step for everyone.

Specialist clinical evaluation

The first step is a thorough clinical evaluation, which includes:

• mode of pain onset
• temporal pattern
• qualitative characteristics (paroxysmal, continuous, burning, heavy)
• distribution over the trigeminal territory
• triggering and relieving factors

The physician also evaluates sensitivity in the V1, V2, and V3 territories, any pain upon touch, and signs of neurological deficit. Previous trauma, herpes zoster, dental treatments, and facial surgeries are important. When indicated, the pathway involves a neurologist, dentist, or other specialists.

Analysis of therapeutic history

The following are critically analysed:

• response to medications
• tolerability
• any procedures already performed
• partial or transient benefits

For each treatment, it is useful to know the dose, duration, benefit, and side effects. A partial response or intolerance to a drug must be distinguished from a trial that was too short or inadequate. Pharmacological response alone does not establish the diagnosis.

Imaging review

In the evaluation of trigeminal neuralgia, guidelines recommend an MRI with dedicated high-resolution sequences to study the nerve and look for secondary causes. The examination helps evaluate:

• relationships between vessels and the trigeminal nerve
• any changes in the shape or volume of the trigeminal root
• possible secondary causes, including space-occupying lesions or demyelinating diseases

A simple contact between vessel and nerve does not confirm the diagnosis on its own. In the classical form, neurovascular compression associated with nerve morphological changes, consistent with the clinical presentation, is what matters. If an MRI cannot be performed, the specialist evaluates alternative investigations. Reference: EAN guidelines.

Diagnosis as a tool for appropriateness

A correct diagnostic pathway allows for:

• reducing unnecessary or ineffective treatments
• limiting unjustified procedural risks
• improving patient adherence to the pathway
• setting realistic goals

In complex trigeminal pain, clinical appropriateness is part of care.

Selective diagnostic tests

In selected cases, the following may be considered:

• local anaesthetic blocks on selected peripheral territories, when a precise clinical question exists
• targeted investigations to clarify alternative diagnoses or possible nerve damage

Relief after a block is an additional element: it does not confirm trigeminal neuralgia on its own and does not guarantee the outcome of radiofrequency. Even the absence of relief must be interpreted considering the technique, territory, and symptoms present at the time of the test.

Final assessment and therapeutic decision

Only after completing the diagnostic pathway is it possible to:

• confirm or exclude trigeminal neuralgia
• distinguish painful trigeminal neuropathy from other forms of persistent facial pain
• evaluate if there are indications for interventional treatments
• or proceed with a conservative approach

In trigeminal neuralgia, carbamazepine and oxcarbazepine are the first-choice drugs, if appropriate for the patient. If control is insufficient or tolerability is poor, procedural and neurosurgical options are discussed. In the classical form, microvascular decompression is a surgical reference; the choice relative to percutaneous techniques depends on the individual clinical picture.

Clinical approach

The diagnostic-therapeutic pathway adopted is based on current clinical and scientific knowledge, integrated with specialist experience in managing complex cases.
Every decision is personalised based on the individual clinical presentation.

Clinical experience

The pathway at PONOS Clinic is managed by Dr. Evangelos Panagiotakos MD, anaesthetist and specialist in interventional pain therapy, with the involvement of other specialists when necessary. Please bring reports and imaging from tests, a list of therapies with doses and duration, documentation of previous procedures, and a pain diary.

Request a specialist assessment

Links to trigeminal pain pages